[go: up one dir, main page]

FI852856A7 - Prostaglandiinianalogeja ja niiden valmistusmenetelmä. - Google Patents

Prostaglandiinianalogeja ja niiden valmistusmenetelmä. Download PDF

Info

Publication number
FI852856A7
FI852856A7 FI852856A FI852856A FI852856A7 FI 852856 A7 FI852856 A7 FI 852856A7 FI 852856 A FI852856 A FI 852856A FI 852856 A FI852856 A FI 852856A FI 852856 A7 FI852856 A7 FI 852856A7
Authority
FI
Finland
Prior art keywords
preparing
prostaglandin analogues
prostaglandin
analogues
Prior art date
Application number
FI852856A
Other languages
English (en)
Swedish (sv)
Other versions
FI852856A0 (fi
FI852856L (fi
Inventor
Katsuhiro Imaki
Hajimu Miyake
Tadao Okegawa
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of FI852856A0 publication Critical patent/FI852856A0/fi
Publication of FI852856A7 publication Critical patent/FI852856A7/fi
Publication of FI852856L publication Critical patent/FI852856L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/005Analogues or derivatives having the five membered ring replaced by other rings
    • C07C405/0075Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a condensed ring system
    • C07C405/0083Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a condensed ring system which is only ortho or peri condensed, e.g. carbacyclins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Emergency Protection Circuit Devices (AREA)
  • Materials For Medical Uses (AREA)
  • Furan Compounds (AREA)
  • Indole Compounds (AREA)
FI852856A 1984-07-23 1985-07-22 Prostaglandinanaloger och foerfaranden foer framstaellning av dessa. FI852856L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59151369A JPS6130554A (ja) 1984-07-23 1984-07-23 プロスタグランジン類似化合物のある特定の立体配置を有する異性体及びそれらを有効成分として含有する治療剤

Publications (3)

Publication Number Publication Date
FI852856A0 FI852856A0 (fi) 1985-07-22
FI852856A7 true FI852856A7 (fi) 1986-01-24
FI852856L FI852856L (fi) 1986-01-24

Family

ID=15517042

Family Applications (1)

Application Number Title Priority Date Filing Date
FI852856A FI852856L (fi) 1984-07-23 1985-07-22 Prostaglandinanaloger och foerfaranden foer framstaellning av dessa.

Country Status (17)

Country Link
US (2) US4935446A (fi)
EP (1) EP0196380B1 (fi)
JP (1) JPS6130554A (fi)
KR (1) KR860001119A (fi)
AT (1) ATE67484T1 (fi)
AU (1) AU596947B2 (fi)
CA (1) CA1264320A (fi)
DE (1) DE3584158D1 (fi)
DK (1) DK333385A (fi)
ES (3) ES8609232A1 (fi)
FI (1) FI852856L (fi)
GR (1) GR851812B (fi)
HU (1) HU199781B (fi)
NO (1) NO852916L (fi)
PT (1) PT80848B (fi)
YU (3) YU45985B (fi)
ZA (1) ZA855533B (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2192395B (en) * 1986-07-08 1990-11-14 Kotobuki Seiyaku Co Ltd Carbacyclin derivatives
US5218139A (en) * 1990-12-27 1993-06-08 G. D. Searle & Co. Method for inhibiting IgE production
US5148032A (en) * 1991-06-28 1992-09-15 Siemens Medical Laboratories, Inc. Radiation emitting device with moveable aperture plate
US5235816A (en) * 1991-10-10 1993-08-17 Praxair Technology, Inc. Cryogenic rectification system for producing high purity oxygen
AR053710A1 (es) * 2005-04-11 2007-05-16 Xenon Pharmaceuticals Inc Compuestos espiroheterociclicos y sus usos como agentes terapeuticos
MY144968A (en) 2005-04-11 2011-11-30 Xenon Pharmaceuticals Inc Spiro-oxindole compounds and their uses as therapeutic agents
LT1976828T (lt) 2005-12-29 2017-04-25 Celtaxsys, Inc. Diamino dariniai, kaip leukotrieno a4 hidrolazės inhibitoriai
CL2007002953A1 (es) * 2006-10-12 2008-02-01 Xenon Pharmaceuticals Inc Compuestos derivados de espiro-oxindol; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del dolor, cancer, prurito, hiperplasia prostatica benigna, hipercolesterolemia.
AR063280A1 (es) 2006-10-12 2009-01-21 Xenon Pharmaceuticals Inc Uso de compuestos de espiro-oxindol como agentes terapeuticos
CA2741029A1 (en) * 2008-10-17 2010-04-22 Xenon Pharmaceuticals Inc. Spiro-oxindole compounds and their use as therapeutic agents
CA2741024A1 (en) * 2008-10-17 2010-04-22 Xenon Pharmaceuticals Inc. Spiro-oxindole compounds and their use as therapeutic agents
AR077252A1 (es) 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
NZ599334A (en) 2009-10-14 2014-03-28 Xenon Pharmaceuticals Inc Synthetic methods for spiro-oxindole compounds
US20110086899A1 (en) * 2009-10-14 2011-04-14 Xenon Pharmaceuticals Inc. Pharmaceutical compositions for oral administration
RU2596488C2 (ru) 2010-02-26 2016-09-10 Ксенон Фармасьютикалз Инк. Фармацевтические композиции спиро-оксиндольного соединения для местного введения и их применение в качестве терапевтических агентов
EA201491854A1 (ru) 2012-04-12 2015-03-31 Ксенон Фармасьютикалз Инк. Асимметрический синтез соединений спирооксиндола, полезных в качестве терапевтических средств
BR112015022226A2 (pt) 2013-03-14 2017-07-18 Celtaxsys Inc inibidores de leucotrieno a4 hidrolase
US9682033B2 (en) 2015-02-05 2017-06-20 Teva Pharmaceuticals International Gmbh Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound
WO2017218920A1 (en) 2016-06-16 2017-12-21 Teva Pharmaceuticals International Gmbh Asymmetric synthesis of funapide
US10385007B2 (en) 2016-12-09 2019-08-20 Celtaxsys, Inc. Monamine and monoamine derivatives as inhibitors of leukotriene A4 hydrolase
EP3551608A1 (en) 2016-12-09 2019-10-16 Celtaxsys Inc. Pendant amines and derivatives as inhibitors of leukotriene a4 hydrolase
WO2018107153A1 (en) 2016-12-09 2018-06-14 Celtaxsys, Inc. Inhibitors of leukotriene a4 hydrolase

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180675A (en) * 1975-07-17 1979-12-25 Warner-Lambert Company 15-Cycloalkyl-prostaglandin derivatives
US4087620A (en) * 1975-07-17 1978-05-02 Ono Pharmaceutical Company 15-Cycloalkyl-prostaglandin derivatives
JPS53103464A (en) * 1977-02-21 1978-09-08 Ono Pharmaceut Co Ltd Prostaglandin x analogues and process for their preparation
US4178367A (en) * 1977-02-21 1979-12-11 Ono Pharmaceutical Co. Ltd. Prostaglandin I2 analogues
JPS53127441A (en) * 1977-04-11 1978-11-07 Ono Pharmaceut Co Ltd Prostaglandin-like compounds and their preparation
GB1588196A (en) * 1977-06-14 1981-04-15 Ono Pharmaceutical Co Prostaglandin analogues
JPS6022710B2 (ja) * 1977-09-16 1985-06-03 小野薬品工業株式会社 プロスタグランジン類似化合物
JPS54125653A (en) * 1978-03-18 1979-09-29 Ono Pharmaceut Co Ltd Prostaglandin i2 analog, its preparation, and drug composition comprising it as active constituent
JPS54130543A (en) * 1978-03-31 1979-10-09 Ono Pharmaceut Co Ltd Prostagladin i2 analog, and its preparation
IT1113341B (it) * 1978-03-31 1986-01-20 Ono Pharmaceutical Co Analoghi della 6,9-metano-pgi2
US4220795A (en) * 1978-08-14 1980-09-02 Miles Laboratories, Inc. Cyclobutyl substituted derivatives of prostaglandin analogs
DE2902809A1 (de) * 1979-01-25 1980-08-07 Hoechst Ag Neue analoga von prostacyclin
DE3006865A1 (de) * 1980-02-23 1981-09-10 Hoechst Ag, 6000 Frankfurt Hetero-imino-prostacycline
JPS58164512A (ja) * 1982-03-25 1983-09-29 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物を有効成分として含有する肝臓疾患治療剤
JPS591463A (ja) * 1982-06-28 1984-01-06 Ono Pharmaceut Co Ltd 新規なプロスタグランジンd類似化合物
JPS5944340A (ja) * 1982-09-08 1984-03-12 Sankyo Co Ltd メタノプロスタサイクリン誘導体の光学活性結晶性アミン塩およびその製法
JPS59163365A (ja) * 1983-03-08 1984-09-14 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物

Also Published As

Publication number Publication date
US4935446A (en) 1990-06-19
YU143387A (en) 1988-04-30
AU596947B2 (en) 1990-05-24
FI852856A0 (fi) 1985-07-22
HU199781B (en) 1990-03-28
PT80848A (en) 1985-08-01
GR851812B (fi) 1985-11-26
EP0196380A3 (en) 1987-07-01
KR860001119A (ko) 1986-02-22
US5109021A (en) 1992-04-28
ES8609232A1 (es) 1986-09-01
ES552553A0 (es) 1987-05-01
DK333385D0 (da) 1985-07-22
DK333385A (da) 1986-01-24
FI852856L (fi) 1986-01-24
YU45985B (sh) 1992-12-21
ATE67484T1 (de) 1991-10-15
PT80848B (pt) 1987-11-30
ES552554A0 (es) 1987-05-01
YU46220B (sh) 1993-05-28
HUT39157A (en) 1986-08-28
YU143287A (en) 1988-04-30
ES8705384A1 (es) 1987-05-01
YU120185A (en) 1988-04-30
CA1264320A (en) 1990-01-09
ZA855533B (en) 1986-03-26
JPS6130554A (ja) 1986-02-12
YU46219B (sh) 1993-05-28
EP0196380A2 (en) 1986-10-08
ES8705385A1 (es) 1987-05-01
AU4523285A (en) 1986-01-30
EP0196380B1 (en) 1991-09-18
NO852916L (no) 1986-01-24
ES545457A0 (es) 1986-09-01
DE3584158D1 (de) 1991-10-24

Similar Documents

Publication Publication Date Title
FI852856A7 (fi) Prostaglandiinianalogeja ja niiden valmistusmenetelmä.
FI851836A7 (fi) Uusien yhdisteiden valmistusmenetelmä.
IT8403463A0 (it) Processo per la preparazionedi pirido-imidazo-rifamicine
FI851837A7 (fi) Uusien yhdisteiden valmistusmenetelmä.
KR860004922A (ko) N-포르밀-α-아스파르틸페닐알라닌의 제조방법
FI854603A7 (fi) Menetelmä ja välituotteet 5-alkyyli-1-fenyyli-2-piperatsino-alkyylipyratsolin-3-oni-yhdisteiden valmistamiseksi.
FI843863A7 (fi) Virustenvastainen koostumus ja menetelmä sen antamiseksi.
KR880701761A (ko) 석탄계 필러의 제조방법
KR860700031A (ko) 살충제 화합물의 제조방법
ES551480A0 (es) Metodo de obtencion de derivados iminotiazolidinicos
DK486985A (da) Fremgangsmaade til fremstilling af tetrahydrofolinsyre
FI855131A7 (fi) Menetelmä 8 -asyyliaminoergoliinin valmistamiseksi
KR860004865A (ko) 옥세타논의 제조방법
FI820396A7 (fi) Menetelmät ja välituotteet pirbuterolin ja sen analogien valmistamiseksi.
FI852772L (fi) Formsten.
TR22560A (tr) Sulfonilguanidinopirimidin tuerevleri
NO161353C (no) Fremgangsmaate for fremstilling av pastiller.
DK329685A (da) Fremgangsmaade til fremstilling af alfa-l-aspartyl-l-phenylalaninalkylestere
FI852751A7 (fi) Menetelmä nitrovinkamiinihappojohdannaisten valmistamiseksi.
DE3678122D1 (de) Herstellungsverfahren von diisopropylcarbinol.
FI855071A7 (fi) Menetelmä monohalogeenihydrokinonien valmistamiseksi.
IT1209936B (it) L-serina metodo per la produzione di
ES555502A0 (es) Metodo de preparacion de carbazatos
ES535617A0 (es) Metodo de preparacion de antitrombina iii
FI821282A7 (fi) Menetelmä 4-okso-PG12 ja niiden analogien valmistamiseksi.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: ONO PHARMACEUTICAL CO LTD